Article
An evaluation of the efficacy of topical application of salicylic acid for the treatment of familial cylindromatosis
24 Mar 2006
Abstract excerpt
BACKGROUND: Familial cylindromatosis is a rare genetic disorder, giving rise to neoplasms of the skin appendages. We have recently shown that loss of the cylindromatosis tumour suppressor gene leads to activation of NF-kappaB, a transcription factor having antiapoptotic activity. This provides a possible explanation for the deregulated growth of cylindromas. In cell-based assays, salicylate can prevent NF-kappaB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
